Samsung Releases Arthritis Drug in First Step Into U.S. Pharmaceuticals

Americans suffering from arthritis can now find relief from an unexpected new player in the pharmaceuticals market.

South Korea’s Samsung conglomerate, best known for its smartphones and televisions, will make available on Monday in the U.S. its lower-price copy of Johnson & Johnson’s blockbuster rheumatoid-arthritis drug Remicade, the second such alternative on the market. The Samsung-developed drug will be marketed to…

from What’s News US

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.